AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]
ABBV/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,214.00 | 15,638.00 | 17,443.00 | 18,380.00 | 18,790.00 | 19,960.00 | 22,859.00 | 25,638.00 | 28,216.00 | 32,753.00 | 33,266.00 | 45,804.00 | 56,197.00 | 58,054.00 | 54,318.00 | |
|
EPS
|
2.87 | 2.59 | 2.12 | 3.35 | 2.58 | 1.11 | 3.15 | 3.65 | 3.31 | 3.69 | 5.30 | 2.73 | 6.48 | 6.65 | 2.73 | |
| Diluted in mil. | 2.85 | 2.57 | 2.11 | 3.35 | 2.56 | 1.10 | 3.13 | 3.63 | 3.30 | 3.68 | 5.28 | 2.72 | 6.45 | 6.63 | 2.72 | |
|
Profit
|
10,157.00 | 11,345.00 | 12,804.00 | 13,872.00 | 14,209.00 | 15,534.00 | 18,359.00 | 19,805.00 | 21,176.00 | 25,035.00 | 25,827.00 | 30,417.00 | 38,751.00 | 40,640.00 | 45,538.00 | |
| Gross Margin | 71.46 | 72.55 | 73.40 | 75.47 | 75.62 | 77.83 | 80.31 | 77.25 | 75.05 | 76.44 | 77.64 | 66.41 | 68.96 | 70.00 | 83.84 | |
| Pre Tax | 5,950.00 | 4,836.00 | 3,668.00 | 5,725.00 | 5,332.00 | 2,369.00 | 6,645.00 | 7,884.00 | 7,727.00 | 5,197.00 | 8,426.00 | 3,398.00 | 12,989.00 | 13,477.00 | 6,250.00 | |
| Profit Margin | 41.86 | 30.92 | 21.03 | 31.15 | 28.38 | 11.87 | 29.07 | 30.75 | 27.39 | 15.87 | 25.33 | 7.42 | 23.11 | 23.21 | 11.51 | |
| ETR | 22.08 | 13.61 | 6.42 | 7.86 | 22.58 | 25.12 | 22.59 | 24.49 | 31.29 | -9.43 | 6.46 | -36.02 | 11.09 | 12.11 | 22.03 | |
| Net | 4,636.00 | 4,178.00 | 3,433.00 | 5,275.00 | 4,128.00 | 1,774.00 | 5,144.00 | 5,953.00 | 5,309.00 | 5,687.00 | 7,882.00 | 4,616.00 | 11,542.00 | 11,836.00 | 4,863.00 | |
| Profit Margin | 32.62 | 26.72 | 19.68 | 28.70 | 21.97 | 8.89 | 22.50 | 23.22 | 18.82 | 17.36 | 23.69 | 10.08 | 20.54 | 20.39 | 8.95 | |
| EBITDA | 5,629.00 | 5,901.00 | 4,892.00 | 6,967.00 | 6,561.00 | 4,197.00 | 8,373.00 | 10,573.00 | 11,093.00 | 8,148.00 | 13,795.00 | 6,947.00 | 26,445.00 | 26,584.00 | 18,096.00 | |
| EBITDA Margin | 34.83 | 40.31 | 35.49 | 39.63 | 34.03 | 24.01 | 35.13 | 39.34 | 37.55 | 24.88 | 41.47 | 15.17 | 47.06 | 45.79 | 33.31 | |
| Operating Income | 4,931.00 | 4,717.00 | 3,620.00 | 5,817.00 | 5,664.00 | 3,411.00 | 7,537.00 | 9,384.00 | 9,592.00 | 6,383.00 | 12,983.00 | 476.00 | 17,924.00 | 18,117.00 | 17,425.00 | |
| Operating Margin | 34.70 | 30.16 | 20.76 | 31.65 | 30.14 | 17.09 | 32.97 | 36.60 | 33.99 | 19.49 | 39.03 | 1.04 | 31.89 | 31.21 | 32.08 | |
| Interest Income | - - | 28.00 | - - | 20.00 | 21.00 | 38.00 | 33.00 | 82.00 | 146.00 | 204.00 | 275.00 | 174.00 | 39.00 | 186.00 | 540.00 | |
| Loss | -9,112.00 | -10,608.00 | -13,150.00 | -12,275.00 | -12,788.00 | -16,197.00 | -15,172.00 | -16,054.00 | -18,297.00 | -25,946.00 | -19,898.00 | -33,243.00 | -37,311.00 | -39,240.00 | -36,893.00 | |
| Cost of Revenue | -4,056.00 | -4,293.00 | -4,639.00 | -4,508.00 | -4,581.00 | -4,426.00 | -4,500.00 | -5,833.00 | -7,040.00 | -7,718.00 | -7,439.00 | -15,387.00 | -17,446.00 | -17,414.00 | -8,780.00 | |
|
Operating Expenses
|
-5,056.00 | -6,315.00 | -8,511.00 | -7,767.00 | -8,207.00 | -11,771.00 | -10,672.00 | -10,221.00 | -11,257.00 | -18,228.00 | -12,459.00 | -17,856.00 | -19,865.00 | -21,826.00 | -28,113.00 | |
| R&D | -1,707.00 | -2,495.00 | -2,617.00 | -2,778.00 | -2,855.00 | -3,297.00 | -4,285.00 | -4,366.00 | -4,982.00 | -10,329.00 | -6,407.00 | -6,557.00 | -7,084.00 | -6,510.00 | -7,032.00 | |
| G&A | -3,348.00 | -3,820.00 | -5,893.00 | -4,989.00 | -5,352.00 | -7,724.00 | -6,387.00 | -5,855.00 | -6,275.00 | -7,399.00 | -5,842.00 | -9,499.00 | -10,249.00 | -13,260.00 | -10,945.00 | |
| SG&A | -3,348.00 | -3,820.00 | -5,893.00 | -4,989.00 | -5,352.00 | -7,724.00 | -6,387.00 | -5,855.00 | -6,275.00 | -7,399.00 | -6,942.00 | -11,299.00 | -12,349.00 | -15,260.00 | -13,145.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1,100.00 | -1,800.00 | -2,100.00 | -2,000.00 | -2,200.00 | |
| Depreciation and Amortization | -697.00 | -1,184.00 | -1,272.00 | -1,150.00 | -897.00 | -786.00 | -836.00 | -1,189.00 | -1,501.00 | -1,765.00 | -2,017.00 | -6,471.00 | -8,521.00 | -8,467.00 | -8,698.00 | |
| Interest Expenses | - - | - - | - - | -104.00 | -278.00 | -391.00 | -686.00 | -965.00 | -1,004.00 | -1,144.00 | -1,509.00 | -2,280.00 | -2,384.00 | -2,230.00 | -1,669.00 | |
| Other Expenses | -848.00 | -222.00 | -624.00 | -296.00 | -392.00 | -1,003.00 | -356.00 | -735.00 | -1,188.00 | -466.00 | -4,557.00 | -2,922.00 | -3,513.00 | -3,293.00 | -11,175.00 | |
|
WA Shares Outstanding
|
1,616.00 | 1,616.00 | 1,616.00 | 1,577.00 | 1,589.00 | 1,595.00 | 1,625.00 | 1,622.00 | 1,596.00 | 1,541.00 | 1,481.00 | 1,667.00 | 1,770.00 | 1,771.00 | 1,768.00 | |
| Diluted | 1,625.00 | 1,625.00 | 1,625.00 | 1,577.00 | 1,604.00 | 1,610.00 | 1,637.00 | 1,631.00 | 1,603.00 | 1,546.00 | 1,484.00 | 1,673.00 | 1,777.00 | 1,778.00 | 1,773.00 |